Form 8-K - Current report:
SEC Accession No. 0001104659-23-069939
Filing Date
2023-06-09
Accepted
2023-06-09 16:31:01
Documents
12
Period of Report
2023-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2318301d1_8k.htm   iXBRL 8-K 40310
  Complete submission text file 0001104659-23-069939.txt   217190

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA azyo-20230608.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20230608_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20230608_pre.xml EX-101.PRE 22589
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2318301d1_8k_htm.xml XML 3749
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

EIN.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 231005812
SIC: 2836 Biological Products, (No Diagnostic Substances)